At a glance
ClinicalIndex Comparison RecordPhase 1Completed· 32 enrolled
Drug / intervention
Blink® Tears eye drops +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Clinical Investigation of Visual Acuity in Contact Lens Wearers After Instillation of a Lipid- Based Lubricating Eye Drop
In Brief
A Phase 1 clinical trial evaluating Blink® Tears eye drops and Investigational lipid eye drops for Visual Acuity. Completed, enrolled 32 participants across 2 sites.
Detailed Summary
This is a single visit, randomized, double masked, bilateral, non-dispensing, 2×2 crossover study to assess visual acuity.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsVisual Acuity
CountriesUnited States
Collaborators--
Timeline
Phase 1CompletedFinished
202120222023202420252026
Enrollment StartSep 2020
Primary CompletionOct 2020
First PostedNov 2023
TodayJul 2026
First PostedNov 14, 2023
Enrollment StartSep 16, 2020
Primary CompletionOct 10, 2020
TodayJul 2, 2026
Enrollment to primary: 24 daysPosted 2.6 years ago
Interventions
Blink® Tears eye dropsdrug
Control Drops
Investigational lipid eye dropsdrug
Test Drops